Atypical chronic myeloid leukemia (CML) with ETV6-ABL1 mutation managed successfully with a third-generation TKI and hematopoietic stem cell transplant
Leuk Lymphoma
.
2025 Jan;66(1):147-149.
doi: 10.1080/10428194.2024.2403666.
Epub 2024 Oct 18.
Authors
S Sharareh Dehghani
1
,
Yanhua Wang
2
,
K H Ramesh
2
,
Dennis Cooper
3
,
Jhannine Alyssa Verceles
3
,
Khaila Boakye
3
,
Marina Konopleva
4
,
Ellen W Friedman
3
,
Aditi Shastri
3
Affiliations
1
Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
2
Department of Pathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
3
Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
4
Department of Medicine (Oncology) and Molecular Pharmacology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
PMID:
39423354
DOI:
10.1080/10428194.2024.2403666
No abstract available